Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.79)
# 553
Out of 4,649 analysts
671
Total ratings
49.9%
Success rate
17.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NGNE Neurogene | Maintained: Buy | $69 → $81 | $36.14 | +124.13% | 4 | Aug 11, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $43 → $35 | $26.49 | +32.13% | 6 | Aug 3, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Buy | $106 → $89 | $57.24 | +55.49% | 13 | Jul 21, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $32.09 | $13.38 | +139.84% | 4 | Jul 9, 2026 | |
| EWTX Edgewise Therapeutics | Maintained: Buy | $51 | $44.17 | +15.46% | 6 | Jul 6, 2026 | |
| SPRB Spruce Biosciences | Initiated Coverage: Buy | $123 | $52.64 | +133.66% | 1 | Jun 16, 2026 | |
| RZLT Rezolute | Rated: Buy | $6 → $11 | $4.60 | +139.13% | 5 | Jun 15, 2026 | |
| BNTC Benitec Biopharma | Downgraded: Hold | n/a | $12.56 | - | 2 | Jun 10, 2026 | |
| NTLA Intellia Therapeutics | Rated: Hold | n/a | $11.91 | - | 7 | Jun 10, 2026 | |
| PASG Passage Bio | Downgraded: Hold | n/a | $4.59 | - | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.99 | +134.11% | 4 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $7.46 | +127.88% | 3 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $3.61 | +343.21% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $3.27 | +572.78% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $7.43 | +155.72% | 16 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $26.98 | +66.79% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $284 | $332.27 | -14.53% | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $9.20 | +182.61% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $46 → $58 | $27.18 | +113.39% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $39 | $35.14 | +10.98% | 2 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $4.84 | +519.83% | 1 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $95 | $48.62 | +95.39% | 64 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $18.10 | +21.55% | 101 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $5 | $3.09 | n/a | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 → $106 | $67.34 | n/a | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 → $546 | $505.75 | n/a | 7 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $55 | $26.75 | n/a | 5 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $50 | $25.70 | n/a | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $53.55 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $228.65 | n/a | 3 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $24 | $5.95 | n/a | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $2.82 | n/a | 1 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 → $16 | $0.175 | n/a | 10 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $20.48 | n/a | 14 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $5.41 | n/a | 19 | Sep 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $31.27 | n/a | 8 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 25.00 | CHF 3.37 | n/a | 7 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $270 → $123 | $27.53 | n/a | 19 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $30 | $15.15 | n/a | 20 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $34.91 | n/a | 19 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $2.15 | n/a | 20 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $2.57 | n/a | 4 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 | $25.12 | n/a | 10 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $2.05 | n/a | 6 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $3.90 | n/a | 5 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $4.22 | n/a | 45 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $26 | $73.02 | n/a | 50 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $13.35 | n/a | 15 | Dec 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $33.56 | n/a | 9 | Aug 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $7 | $114.47 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $1.5 | $0.93 | n/a | 5 | Oct 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.5 → $10 | $15.94 | n/a | 23 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $63 | $71.70 | n/a | 19 | Oct 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.341827 | n/a | 7 | Aug 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $16 | $8.23 | n/a | 13 | Aug 14, 2015 |
Neurogene
Aug 11, 2026
Maintained: Buy
Price Target: $69 → $81
Current: $36.14
Upside: +124.13%
Ultragenyx Pharmaceutical
Aug 3, 2026
Maintained: Buy
Price Target: $43 → $35
Current: $26.49
Upside: +32.13%
Ionis Pharmaceuticals
Jul 21, 2026
Maintained: Buy
Price Target: $106 → $89
Current: $57.24
Upside: +55.49%
Satellos Bioscience Inc.
Jul 9, 2026
Maintained: Buy
Price Target: $32.09
Current: $13.38
Upside: +139.84%
Edgewise Therapeutics
Jul 6, 2026
Maintained: Buy
Price Target: $51
Current: $44.17
Upside: +15.46%
Spruce Biosciences
Jun 16, 2026
Initiated Coverage: Buy
Price Target: $123
Current: $52.64
Upside: +133.66%
Rezolute
Jun 15, 2026
Rated: Buy
Price Target: $6 → $11
Current: $4.60
Upside: +139.13%
Benitec Biopharma
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $12.56
Upside: -
Intellia Therapeutics
Jun 10, 2026
Rated: Hold
Price Target: n/a
Current: $11.91
Upside: -
Passage Bio
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.59
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.99
Upside: +134.11%
Jun 5, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $7.46
Upside: +127.88%
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $3.61
Upside: +343.21%
Jun 2, 2026
Maintained: Buy
Price Target: $22
Current: $3.27
Upside: +572.78%
May 28, 2026
Maintained: Buy
Price Target: $19
Current: $7.43
Upside: +155.72%
May 7, 2026
Maintained: Buy
Price Target: $45
Current: $26.98
Upside: +66.79%
May 4, 2026
Reiterated: Buy
Price Target: $284
Current: $332.27
Upside: -14.53%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $9.20
Upside: +182.61%
Mar 4, 2026
Rated: Buy
Price Target: $46 → $58
Current: $27.18
Upside: +113.39%
Dec 3, 2025
Maintained: Buy
Price Target: $32 → $39
Current: $35.14
Upside: +10.98%
Oct 15, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $4.84
Upside: +519.83%
Sep 24, 2025
Maintained: Buy
Price Target: $28 → $95
Current: $48.62
Upside: +95.39%
Sep 15, 2025
Reiterated: Buy
Price Target: $22
Current: $18.10
Upside: +21.55%
Aug 13, 2025
Maintained: Buy
Price Target: $20 → $5
Current: $3.09
Upside: n/a
Aug 6, 2025
Maintained: Buy
Price Target: $110 → $106
Current: $67.34
Upside: n/a
Aug 6, 2025
Maintained: Buy
Price Target: $450 → $546
Current: $505.75
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $78 → $55
Current: $26.75
Upside: n/a
Aug 14, 2024
Maintained: Buy
Price Target: $45 → $50
Current: $25.70
Upside: n/a
Jun 28, 2024
Rated: Hold
Price Target: n/a
Current: $53.55
Upside: n/a
Jun 27, 2022
Downgraded: Hold
Price Target: n/a
Current: $228.65
Upside: n/a
Apr 5, 2022
Maintained: Buy
Price Target: $28 → $24
Current: $5.95
Upside: n/a
Mar 17, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $2.82
Upside: n/a
Jan 6, 2021
Initiated Coverage: Hold
Price Target: $14 → $16
Current: $0.175
Upside: n/a
Sep 3, 2020
Reiterated: Buy
Price Target: $17
Current: $20.48
Upside: n/a
Sep 1, 2020
Maintained: Buy
Price Target: $20
Current: $5.41
Upside: n/a
Aug 31, 2020
Reiterated: Buy
Price Target: $30
Current: $31.27
Upside: n/a
Aug 28, 2020
Reiterated: Buy
Price Target: CHF 25.00
Current: CHF 3.37
Upside: n/a
Aug 24, 2020
Downgraded: Hold
Price Target: $270 → $123
Current: $27.53
Upside: n/a
Aug 11, 2020
Maintained: Buy
Price Target: $36 → $30
Current: $15.15
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $13
Current: $34.91
Upside: n/a
Aug 7, 2020
Reiterated: Buy
Price Target: $24
Current: $2.15
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $42
Current: $2.57
Upside: n/a
Aug 6, 2020
Maintained: Buy
Price Target: $54
Current: $25.12
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $49
Current: $2.05
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $25
Current: $3.90
Upside: n/a
Jul 31, 2020
Reiterated: Buy
Price Target: $40
Current: $4.22
Upside: n/a
May 12, 2020
Reiterated: Hold
Price Target: $32 → $26
Current: $73.02
Upside: n/a
Dec 18, 2019
Maintained: Buy
Price Target: $2
Current: $13.35
Upside: n/a
Aug 1, 2017
Maintained: Hold
Price Target: n/a
Current: $33.56
Upside: n/a
Dec 20, 2016
Initiated Coverage: Sell
Price Target: $7
Current: $114.47
Upside: n/a
Oct 20, 2016
Maintained: Hold
Price Target: $9 → $1.5
Current: $0.93
Upside: n/a
Oct 26, 2015
Initiated Coverage: Buy
Price Target: $7.5 → $10
Current: $15.94
Upside: n/a
Oct 16, 2015
Maintained: Hold
Price Target: $63
Current: $71.70
Upside: n/a
Aug 16, 2015
Maintained: Buy
Price Target: $4
Current: $0.341827
Upside: n/a
Aug 14, 2015
Reiterated: Buy
Price Target: $10 → $16
Current: $8.23
Upside: n/a